Rating History for X4 Pharmaceuticals (XFOR) by Wells Fargo
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/10/2026 | Derek Archila | New Coverage | Overweight (N/A) |
11.00 (N/A) |
3.96 (3.82) |
-3.54% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/10/2026 | Derek Archila | New Coverage | Overweight (N/A) |
11.00 (N/A) |
3.96 (3.82) |
-3.54% | Details |